Objectives: Type-2 diabetes mellitus (T2DM) is an endocrine disease having a significant genetic component. Polymorphisms of many genes may affect hereditary vulnerability of the disease that is characterized by insulin resistance and islet disorder. As the genetic basis of T2DM can vary between ethnic groups, it is important to investigate the genetic link of T2DM in Pakistani populace. This study was aimed to assess the association of receptor for advanced glycation end product (RAGE) gene polymorphism (-429T>C) with Type-2 diabetes mellitus within local populace. Methods: Genomic DNA was isolated by following kit protocol. Genotyping of the RAGE gene was studied by PCR-RFLP on genomic DNA. All research work was done in molecular biochemistry laboratory (MBL), University of Agriculture Faisalabad and Postgraduate Laboratory, The University of Faisalabad, Pakistan from December 2016 to July 2017. Results: We found distribution of -429T>C genotypes between T2DM and healthy controls as 24.7% (tt), 24.7% (Tt) and 50.7% (TT). The outcomes were highly compatible statistically.
INTRODUCTION
Diabetes mellitus (DM) is a polygenic disorder. It may also be called a heterogeneous abnormality. It needs lifelong care. This problem is characterized by chronic symptoms such as high blood glucose level. The metabolism of macromolecules is defective due to impaired hypoglycemic hormone secretion, its action or both. Multifactorial etiology points towards the lifestyle as major predisposing factor. 1 The cell types which express RAGE include endothelium, monocytes/macrophages, Tlymphocytes, neuronal cells and glomerular epithelial cells. 2, 3 Although RAGE genes has been topic of interest in many studies involving various ethnic populations to explore its link with Type-2 diabetes and post diabetic manifestations but results observed were conflicting.
Genetics being an important player for the progression of this disease identifies individuals at risk of developing T2DM. Purpose of present study was to assess the two RAGE genetic polymorphisms found exclusively in promoter region and to reveal how RAGE genotypes and allelic distribution directly affects disease prevalence in Pakistani population.
METHODS

Sample collection:
Blood samples from 50 normal individuals and 100 patients suffering from Type-2 diabetes mellitus (T2DM) admitted to Allied Hospital, Faisalabad and Madina Teaching Hospital Faisalabad, Pakistan were collected. All the molecular research was conducted in ClinicoBiochemistry Laboratory (CBL) and Molecular Biochemistry Laboratory (MBL), Department of Biochemistry, University of Agriculture Faisalabad (UAF), Pakistan from December 2016 to July 2017. DNA extraction: Genomic DNA was extracted by using blood genomic DNA isolation kit (FavorPrep Blood Genomic DNA Extraction Mini Kit, Biotech Corp, Taiwan). Two hundred μL samples (whole blood) were shifted to a centrifuge tube followed by the addition of 200μL FABG buffer and 20μL proteinase K sequentially. It was mixed thoroughly by pulse-vortexing. The mixture was incubated at 60°C for 15 minutes to lyse the contents of the sample. During this incubation, sample was vortexed after every 3-5 minutes. It was followed by addition of 200 μL of ethanol (96-100 %) and pulsevortexing for 10 seconds.
The whole mixture with sediments was shifted to a FABG mini column placed in a tube and centrifuged for one minute at 6000 × g. The FABG, mini.column was placed in another tube and 40μL of W1 (buffer) was added. It was placed in a separator for 30 seconds at optimum speed (18,000 × g) and the flow-through was discarded. It was followed by the addition of 750μL of washing buffer to the FABG mini column. It was centrifuged for 30 seconds at full speed and eluent was discarded. Further centrifugation for three minutes at full speed was done in order to dry the column. This step inhibited subsequent enzymatic reaction. The FABG mini column was placed in an elution tube and 60 ~ 200 μL of elution buffer (pH 7.5-9.0) was put on the membrane of FABG mini column. The FABG mini column was placed in a standing position for three minutes. For elution it is necessary to dispense elution solution onto the membrane center and it should be completely absorbed. Finally it was centrifuged at 6000 × g speed for one minute to elute total DNA. The extracted DNA was stored at 4°C. Quantification of DNA: The quantity of the DNA was determined by measuring the absorbance of DNA samples (A 260 /A 280 ). Quality of the DNA was assessed on 0.8% agarose gel. By using 1X TAE buffer, the gel was run (80 V), stained in ethidium bromide for 15-20 minutes and documented in gel documentation system. Single nucleotide polymorphism (SNP) of RAGE gene: SNP was selected from promoter region of RAGE gene for analysis in diabetic patients as well as in healthy subjects. RAGE gene primer: The primer used for the selected variant (-429T/C (rs1800625) of RAGE gene is mentioned below.
F: GGGGCA GTTCTCTCCTCACT and R: GGTTCAGGCCAGACTGTTGT Primer designing: Primers were designed using "primer 3" software (http://primer3.wi.mit. edu/). Polymerase Chain Reaction (PCR): PCR conditions were optimized for annealing temperature and magnesium concentration. A PCR kit provided by Thermo SCIENTIFC TM (U.S.A) was used. All PCRs was done in duplicates to minimize the variations. The composition of a 25 μL PCR mixture was 2.5 μL (2 mm) dNTPs, 2.5 μL 10X Taq DNA polymerase buffer, 2.5 µL (25 mm) MgCl 2 , 1 µm forward primer, 1 µm reverse primer, 0.5 μLTaq DNA polymerase, 1.0 μg genomic DNA and nuclease free water to make up the volume. PCR reaction was run in a thermal cycler with following conditions: 95°C for 5 minutes followed by 25 cycles of 94°C for 30 seconds, 53°C for 30 seconds, 65°C for 4 minute with a final extension of 5 minute at 65°C. Enzymatic digestion: After amplification with PCR, all amplified fragments were subjected to digestion using specific enzyme under optimum conditions of temperature and time allowing access to genotype of each individual. The selected restriction enzyme was: AluI (rs1800625) for RAGE polymorphic sites -429T/C. 
RESULTS
-429T>C polymorphism in control group and T2DM patients: Genetics being an important player for the progression of this disease identifies individuals at risk of developing T2DM. Purpose of present study was to assess the RAGE genetic polymorphisms found exclusively in promoter region and to reveal how RAGE genotypes and allelic distribution directly affects disease prevalence in Pakistani population.
The digested products were directly electrophoresed on 2.5% (w/v) agarose gel with ethidium bromide and the results were recorded using a gel documentation system. Enzymatic digestion was done for verification of all the distinctive genotypes.
Fragments of 166 bp and 84 bp for -429T>C allele were produced after digestion with AluI. The size of unrestricted fragment was 250bp.
The -429T>C genotype fragments indicated heterozygosity (Tt) after digestion with restriction enzyme AluI (rs1800625). -429T>C genotypeis present in the promoter region of RAGE gene; hence polymorphism of this region may have an impact on RAGE protein structure and may be involved in pathogenesis of T2DM. However, Kang et al. (2012) demonstrated that this variant of RAGE gene had no impact in T2DM pathogenesis and metabolic parameters to justify the hypothesis that -429T>C may be prone to cause diabetic micro-vascular complications. 6 In view of current study -429T>C allelic frequencies were statistically non-significant between control and T2DM groups. Distribution of -429T>C genotypes between T2DM and healthy controls were 24.7% (tt), 24.7% (Tt) and 50.7% (TT).
DISCUSSION
The RAGE gene (chromosome 6; 6p21.3) is located near a histocompatibility complex. 7 Promoter RAGE polymorphisms -429T>C (rs1800625) and 63 bp deletion (-345 to -407 bp) are associated with an increase in RAGE expression 8 and diseases related with immune system such as systemic lupus erythematosus, Crohn's disease 9 and DM. 10 Engelen et al. 11 depicted that the metabolic impairment due to hyperglycemia influence RAGE polymorphism. As T2DM is a multidimensional disease, a polymorphism as prominent etiological factor in one ethnic group may not have the same link in other ethnic populations. 12 Furthermore, Li et al. 13 stated that the incidence of RAGE gene polymorphism may vary depending upon type of diabetes and ethnic background. Receptor for AGEs is mostly expressed at the level of transcription of mRNA and translation of protein during initial RAGE gene polymorphism in local population 
